Upgrade to SI Premium - Free Trial

UPDATE: Neurocrine Bio. (NBIX) PT Lowered to $95 at Mizuho Securities

February 14, 2022 6:54 AM
(Updated - February 14, 2022 8:55 AM EST)

Mizuho Securities analyst Vamil Divan lowered the price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles